Literature DB >> 16459494

Audit of nasendoscope disinfection practice.

I Street1, J Hamann, M Harries.   

Abstract

INTRODUCTION: Several options exist with regard to flexible pharyngo-laryngoscope sterilisation. We audited the use of disposable sheaths in our department over a six-month period.
METHODS: A cost-analysis was performed and the advantages and disadvantages of this system were compared with several alternative options.
RESULTS: We found that the overall cost of disposable sheaths averaged ł4008 per month over a six-month period. We subsequently introduced chlorine dioxide (ClO2) wipes as a means of disinfection. Chlorine dioxide wipes have enabled a monthly saving of ł3145 over sheath usage. Additionally, they meet health regulation requirements and are a convenient, cost-effective alternative to sheaths. DISCUSSION: The limiting factors, including time and financial issues, involved in nasendoscope disinfection are discussed.
CONCLUSIONS: We have found chlorine dioxide wipes to be a satisfactory alternative means of nasendoscope disinfection. Possible time constraints aside, there are no advantages of sheath use over our current method. Chlorine dioxide wipes are also preferable from a financial point of view.

Entities:  

Mesh:

Year:  2006        PMID: 16459494     DOI: 10.1016/s1479-666x(06)80015-6

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  2 in total

1.  Evaluation of disinfection of flexible nasendoscopes using Tristel wipes: a prospective single blind study.

Authors:  K Tzanidakis; N Choudhury; S Bhat; A Weerasinghe; J Marais
Journal:  Ann R Coll Surg Engl       Date:  2012-04       Impact factor: 1.891

2.  Time-effectiveness and convenience of transvaginal ultrasound probe disinfection using ultraviolet vs chlorine dioxide multistep wipe system: prospective survey study.

Authors:  C Kyriacou; E Robinson; J Barcroft; N Parker; M Tuomey; C Stalder; D Gould; M Al-Memar; T Bourne
Journal:  Ultrasound Obstet Gynecol       Date:  2022-07       Impact factor: 8.678

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.